Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-25-067035
Filing Date
2025-07-10
Accepted
2025-07-10 17:10:14
Documents
16

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2520540d1_defa14a.htm DEFA14A 23565
2 GRAPHIC tm2520540d1_defa14a-img01.jpg GRAPHIC 118966
3 GRAPHIC tm2520540d1_defa14a-img02.jpg GRAPHIC 342464
4 GRAPHIC tm2520540d1_defa14a-img03.jpg GRAPHIC 264480
5 GRAPHIC tm2520540d1_defa14a-img04.jpg GRAPHIC 286209
6 GRAPHIC tm2520540d1_defa14a-img05.jpg GRAPHIC 136247
7 GRAPHIC tm2520540d1_defa14a-img06.jpg GRAPHIC 147598
8 GRAPHIC tm2520540d1_defa14a-img07.jpg GRAPHIC 173603
9 GRAPHIC tm2520540d1_defa14a-img08.jpg GRAPHIC 198348
10 GRAPHIC tm2520540d1_defa14a-img09.jpg GRAPHIC 149096
11 GRAPHIC tm2520540d1_defa14a-img10.jpg GRAPHIC 152476
12 GRAPHIC tm2520540d1_defa14a-img11.jpg GRAPHIC 171344
13 GRAPHIC tm2520540d1_defa14a-img12.jpg GRAPHIC 110864
14 GRAPHIC tm2520540d1_defa14a-img13.jpg GRAPHIC 153454
15 GRAPHIC tm2520540d1_defa14a-img14.jpg GRAPHIC 175937
16 GRAPHIC tm2520540d1_defa14a-img15.jpg GRAPHIC 24739
  Complete submission text file 0001104659-25-067035.txt   3615803
Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE 011-44-0-2032834200
Verona Pharma plc (Filer) CIK: 0001657312 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38067 | Film No.: 251116952
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)